e-Submissions & Data Standards for FDA (eCTD, CDISC, HL7) - Webinar By GlobalCompliancePanel
View: 211
Website http://bit.ly/11OTIGT |
Edit Freely
Category Medical Device, Pharma, Biotech, Clinical, Drug, Food Safety, Heath,FDA
Deadline: April 25, 2013 | Date: April 25, 2013
Venue/Country: California, U.S.A
Updated: 2013-04-08 17:41:34 (GMT+9)
Call For Papers - CFP
Overview: Each FDA center has different guidelines and processes to follow in order to have a successful submission for the regulatory review of the medical product. The submission process for drugs, biologics and medical devices is rigorous and has specific timelines and standards to follow. The agencies (FDA, EMEA) encourage electronic submissions and they have developed data standards and other guidelines. The Common Technical Document (CTD) describes the modules, sections and documents to be used by an Applicant for a Marketing Authorization for a medical product for human use ( EU, Japan and US). Different Standard Development Organizations (HL7, ISO, CDISC, ICH) work to produce and harmonize standards nationally and worldwide to improve regulatory submissions. Why Should You Attend: This webinar will provide the new and expected guidances on data standards and electronic submissions for drugs and medical products. We will explain what are the policies and the requirements for submissions and standards for drugs in US and globally and how it affects healthcare/drug industry to adopt them.All functional groups and professionals who have responsibility in the submissions and approval process for medical products and need to have an overview of the field should attend.Areas Covered in the Session:Overview: Approval Process for Drugs, Biologics and DevicesSubmission Requirements & Guidances, FDAElectronic Regulatory Submission & Gateway, FDAe-Submissions, EMEA, EU and globallyInternational Conference on Harmonization (ICH)Electronic Common Technical Document (eCTD), ICHeCTD Guidance and Specifications, FDAHealth Level 7 Regulated Clinical Research Information ManagementClinical Data Interchange Standards Consortium, (SDTM, SEND, ADAM)Biomedical Research Integrated Domain Group(NIH, FDA, CDISC, HL7)Benefits and Challenges with Data Standards worldwideWho Will Benefit:Management (Pharma, Biotech)Policy analystsGovernment officersHealth IT Managers and AnalystsResearch and Development (Pharmaceutical, Academia)Regulatory Affairs personnelQuality assurance/quality control personnelAuditors and inspectorsEntrepreneurs InvestorsKosta Makrodimitris, PhD, CF-FDA, CP-EHR, is Biomedical/Health Informatics Advisor, Author & Strategist. Dr. Makrodimitris is the principal for K Makrodimitris that specializes in Health IT & BIO business development, eHealth education, Health Information policy. Price: $225.00GlobalCompliancePanel NetZealous LLC,161 Mission Falls Lane,Suite 216, Fremont, CA 94539, USAUSA Phone:800-447-9407Fax: 302-288-6884webinars
globalcompliancepanel.com http://www.globalcompliancepanel.com
http://bit.ly/11OTIGT
Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.